Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Adam Keeney is Head of Corporate Development at Biogen. OQRO lists 10 transactions filed with the SEC under this name, the latest on May 5, 2026, each linked to the official Form 4.
Head of Corporate Development
Disclosures on record
10
Companies involved
1
BiogenBIIB
10 disclosures · Feb 2026 – May 2026
May 1, 2026939disclosed May 5
DetailsOfficial recordMay 1, 2026939disclosed May 5
DetailsOfficial recordMay 1, 2026455disclosed May 5
DetailsOfficial recordFeb 13, 20268,025disclosed Feb 18
DetailsOfficial recordFeb 6, 20263,278disclosed Feb 10
DetailsOfficial recordFeb 6, 20261,802disclosed Feb 10
DetailsOfficial recordFeb 6, 20263,278disclosed Feb 10
DetailsOfficial recordFeb 6, 20261,802disclosed Feb 10
DetailsOfficial recordFeb 6, 2026589disclosed Feb 10
DetailsOfficial recordFeb 6, 2026994disclosed Feb 10
DetailsOfficial recordAs of the latest filing on , Adam Keeney reported holding 6,365 shares of Biogen (BIIB), worth about $1.6M at the last close of $251 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Biogen BIIB | 6,365 | 6,365 direct | $251 | $1.6M | May 1, 2026 |
Is this Adam Keeney’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated May 1, 2026, Adam Keeney reported holding 6,365 shares of Biogen (BIIB). At the last close of $251 on Nov 18, 2026, that is about $1.6M. This is the stake disclosed in filings, not a net worth.
No public filing gives Adam Keeney's net worth. What SEC Form 4 shows is the stock stake: 6,365 shares of Biogen (BIIB), about $1.6M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.